EBS Competitors & Alternatives

Compare Emergent Biosolutions Inc with similar stocks in the same industry

Drug Manufacturers - Specialty & Generic

EBS

Main Stock
$7.55
Tradestie Score
57
Market Cap
$490.30M
Revenue Growth
-0.3%
Analyst Upside
+59.0%

Top Competitors

48 stocks in Drug Manufacturers - Specialty & Generic
Company Price Market Cap P/E Score Action
DVAX Dynavax Technologies Corporation
$15.50
$1.21B - 55 Compare
PCRX Pacira BioSciences, Inc. Common Stock
$25.34
$1.14B 196.0 59 Compare
COLL Collegium Pharmaceutical, Inc. Common Stock
$34.73
$1.11B 17.1 55 Compare
CRON Cronos Group Inc. Common Share
$2.75
$1.02B - 61 Compare
VIR Vir Biotechnology, Inc. Common Stock
$9.56
$791.82M - 49 Compare
AQST Aquestive Therapeutics, Inc. Common Stock
$4.06
$711.32M - 53 Compare
ESPR Esperion Therapeutics, Inc.
$3.18
$584.71M - 55 Compare
ETON Eton Pharmaceutcials, Inc. Common Stock
$37.57
$543.32M - 58 Compare
IRWD Ironwood Pharmaceuticals, Inc. - Class A
$4.04
$237.15M 7.2 60 Compare
BIOA BioAge Labs, Inc. Common Stock
$22.20
$212.23M - 55 Compare

Data updated: Jul 14, 2026 | Industry: Drug Manufacturers - Specialty & Generic (SIC 2834)

48 stocks in this industry